Rank | Gene Set | Z-score |
---|---|---|
1 | * eosinophil chemotaxis (GO:0048245) | 7.69171877 |
2 | fat-soluble vitamin biosynthetic process (GO:0042362) | 7.45938899 |
3 | * eosinophil migration (GO:0072677) | 6.68483132 |
4 | glycosphingolipid catabolic process (GO:0046479) | 6.54552472 |
5 | monocyte chemotaxis (GO:0002548) | 6.30046254 |
6 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 6.27148580 |
7 | neutrophil activation involved in immune response (GO:0002283) | 6.16796701 |
8 | glycolipid catabolic process (GO:0019377) | 5.95338721 |
9 | positive regulation of bone resorption (GO:0045780) | 5.86705419 |
10 | positive regulation of bone remodeling (GO:0046852) | 5.86705419 |
11 | oligosaccharide catabolic process (GO:0009313) | 5.82774857 |
12 | cellular response to ethanol (GO:0071361) | 5.81353583 |
13 | phagocytosis, engulfment (GO:0006911) | 5.49898239 |
14 | regulation of lymphocyte chemotaxis (GO:1901623) | 5.46514072 |
15 | ceramide catabolic process (GO:0046514) | 5.28573142 |
16 | lipoxygenase pathway (GO:0019372) | 5.20447217 |
17 | cellular response to thyroid hormone stimulus (GO:0097067) | 5.08009957 |
18 | pinocytosis (GO:0006907) | 5.01147480 |
19 | amino sugar catabolic process (GO:0046348) | 4.90964006 |
20 | positive regulation of lymphocyte migration (GO:2000403) | 4.84392200 |
21 | cellular extravasation (GO:0045123) | 4.76874336 |
22 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.76547484 |
23 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.72024323 |
24 | regulation of MHC class II biosynthetic process (GO:0045346) | 4.54333790 |
25 | membrane lipid catabolic process (GO:0046466) | 4.52700475 |
26 | vitamin D metabolic process (GO:0042359) | 4.51248642 |
27 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 4.46982553 |
28 | osteoclast differentiation (GO:0030316) | 4.45362668 |
29 | peptide catabolic process (GO:0043171) | 4.45347267 |
30 | microglial cell activation (GO:0001774) | 4.38929475 |
31 | regulation of apoptotic cell clearance (GO:2000425) | 4.35337235 |
32 | regulation of lymphocyte migration (GO:2000401) | 4.24082222 |
33 | macrophage activation involved in immune response (GO:0002281) | 4.22805764 |
34 | response to peptidoglycan (GO:0032494) | 4.19553212 |
35 | positive regulation of macrophage differentiation (GO:0045651) | 4.13348846 |
36 | barbed-end actin filament capping (GO:0051016) | 4.10919462 |
37 | macrophage activation (GO:0042116) | 4.07587815 |
38 | glucosamine-containing compound catabolic process (GO:1901072) | 4.04522159 |
39 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.02788749 |
40 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.97571476 |
41 | phagosome maturation (GO:0090382) | 3.95830327 |
42 | response to thyroid hormone (GO:0097066) | 3.95758981 |
43 | sexual reproduction (GO:0019953) | 3.95237727 |
44 | phospholipid efflux (GO:0033700) | 3.92418455 |
45 | positive regulation of leukocyte degranulation (GO:0043302) | 3.92129097 |
46 | superoxide anion generation (GO:0042554) | 3.87967673 |
47 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.87527977 |
48 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.87527977 |
49 | modulation by symbiont of host immune response (GO:0052553) | 3.87527977 |
50 | positive regulation by symbiont of host defense response (GO:0052509) | 3.87527977 |
51 | modulation by symbiont of host defense response (GO:0052031) | 3.87527977 |
52 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.87527977 |
53 | positive regulation of tissue remodeling (GO:0034105) | 3.86634967 |
54 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.85479646 |
55 | membrane invagination (GO:0010324) | 3.81351547 |
56 | positive regulation of cholesterol efflux (GO:0010875) | 3.81011967 |
57 | regulation of macrophage chemotaxis (GO:0010758) | 3.79702423 |
58 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.79433463 |
59 | positive regulation of interferon-alpha production (GO:0032727) | 3.78926103 |
60 | negative regulation of granulocyte differentiation (GO:0030853) | 3.77587082 |
61 | sphingolipid catabolic process (GO:0030149) | 3.76315547 |
62 | regulation of interferon-alpha production (GO:0032647) | 3.72417071 |
63 | granulocyte activation (GO:0036230) | 3.71796473 |
64 | regulation of mononuclear cell migration (GO:0071675) | 3.70710317 |
65 | bile acid biosynthetic process (GO:0006699) | 3.69459307 |
66 | regulation of monocyte differentiation (GO:0045655) | 3.65563566 |
67 | positive regulation of extracellular matrix organization (GO:1903055) | 3.64084721 |
68 | lens fiber cell differentiation (GO:0070306) | 3.63158164 |
69 | myeloid cell activation involved in immune response (GO:0002275) | 3.62761062 |
70 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.62151525 |
71 | negative regulation of interleukin-17 production (GO:0032700) | 3.61550555 |
72 | neutrophil chemotaxis (GO:0030593) | 3.59901589 |
73 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.56394991 |
74 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.56033843 |
75 | vitamin biosynthetic process (GO:0009110) | 3.54970464 |
76 | lymphocyte chemotaxis (GO:0048247) | 3.53415900 |
77 | negative regulation of interleukin-12 production (GO:0032695) | 3.51454007 |
78 | neutrophil migration (GO:1990266) | 3.50724927 |
79 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.49133595 |
80 | regulation of monocyte chemotaxis (GO:0090025) | 3.48249082 |
81 | neutrophil activation (GO:0042119) | 3.47739877 |
82 | response to muramyl dipeptide (GO:0032495) | 3.46185556 |
83 | positive regulation of sterol transport (GO:0032373) | 3.46014749 |
84 | positive regulation of cholesterol transport (GO:0032376) | 3.46014749 |
85 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.45308085 |
86 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.44400971 |
87 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.39494798 |
88 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.39239379 |
89 | reactive oxygen species biosynthetic process (GO:1903409) | 3.34302463 |
90 | glucose 6-phosphate metabolic process (GO:0051156) | 3.32854629 |
91 | plasma lipoprotein particle assembly (GO:0034377) | 3.31484141 |
92 | positive regulation of mast cell activation (GO:0033005) | 3.31095139 |
93 | positive regulation of B cell differentiation (GO:0045579) | 3.30837334 |
94 | decidualization (GO:0046697) | 3.25089179 |
95 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.23989948 |
96 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.21186255 |
97 | positive regulation of mast cell degranulation (GO:0043306) | 3.19802270 |
98 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.19802270 |
99 | cellular response to zinc ion (GO:0071294) | 3.17399725 |
100 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.17182191 |
101 | myeloid dendritic cell differentiation (GO:0043011) | 3.16935106 |
102 | leukotriene biosynthetic process (GO:0019370) | 3.15919006 |
103 | complement activation, alternative pathway (GO:0006957) | 3.15896342 |
104 | macrophage differentiation (GO:0030225) | 3.14025806 |
105 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.13550804 |
106 | detection of molecule of bacterial origin (GO:0032490) | 3.12722349 |
107 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.12349553 |
108 | macrophage chemotaxis (GO:0048246) | 3.11768838 |
109 | positive regulation of antigen processing and presentation (GO:0002579) | 3.11226592 |
110 | cellular response to cadmium ion (GO:0071276) | 3.10872212 |
111 | T cell migration (GO:0072678) | 3.10695638 |
112 | * granulocyte chemotaxis (GO:0071621) | 3.09801633 |
113 | respiratory burst (GO:0045730) | 3.09502425 |
114 | transferrin transport (GO:0033572) | 3.09265627 |
115 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.09261255 |
116 | reverse cholesterol transport (GO:0043691) | 3.06305446 |
117 | positive regulation of leukocyte chemotaxis (GO:0002690) | 3.05704052 |
118 | regulation of bone resorption (GO:0045124) | 3.05228560 |
119 | low-density lipoprotein particle remodeling (GO:0034374) | 3.04300791 |
120 | apoptotic cell clearance (GO:0043277) | 3.03406415 |
121 | positive regulation of calcium ion import (GO:0090280) | 3.03364236 |
122 | L-glutamate transport (GO:0015813) | 3.03301985 |
123 | detection of other organism (GO:0098543) | 3.01383252 |
124 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.00596244 |
125 | cyclooxygenase pathway (GO:0019371) | 2.98567577 |
126 | myeloid dendritic cell activation (GO:0001773) | 2.97451257 |
127 | positive regulation of T cell migration (GO:2000406) | 2.97021731 |
128 | regulation of interleukin-1 secretion (GO:0050704) | 2.96889460 |
129 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.96528452 |
130 | leukotriene metabolic process (GO:0006691) | 2.96042526 |
131 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.95773759 |
132 | negative regulation of bone resorption (GO:0045779) | 2.95257240 |
133 | * granulocyte migration (GO:0097530) | 2.95074723 |
134 | response to lipoprotein particle (GO:0055094) | 2.92499094 |
135 | regulation of cholesterol storage (GO:0010885) | 2.92090154 |
136 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.91445213 |
137 | protein-lipid complex assembly (GO:0065005) | 2.90326684 |
138 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.90296279 |
139 | regulation of mast cell activation (GO:0033003) | 2.88448131 |
140 | mannose metabolic process (GO:0006013) | 2.88306285 |
141 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.87370311 |
142 | protein localization to endosome (GO:0036010) | 2.87121628 |
143 | positive regulation of phagocytosis (GO:0050766) | 2.86786740 |
144 | regulation of integrin activation (GO:0033623) | 2.86364812 |
145 | regulation of leukocyte chemotaxis (GO:0002688) | 2.85120849 |
146 | immunoglobulin mediated immune response (GO:0016064) | 2.85029328 |
147 | negative regulation of lipid storage (GO:0010888) | 2.83799293 |
148 | regulation of T cell migration (GO:2000404) | 2.83742211 |
149 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.83697220 |
150 | regulation of leukocyte degranulation (GO:0043300) | 2.83440766 |
151 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.83351332 |
152 | * leukocyte chemotaxis (GO:0030595) | 2.83243631 |
153 | trivalent inorganic cation transport (GO:0072512) | 2.83059392 |
154 | ferric iron transport (GO:0015682) | 2.83059392 |
155 | regulation of macrophage differentiation (GO:0045649) | 2.82195752 |
156 | regulation of antigen processing and presentation (GO:0002577) | 2.81819271 |
157 | regulation of platelet activation (GO:0010543) | 2.81715436 |
158 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.81518488 |
159 | polyol biosynthetic process (GO:0046173) | 2.81470322 |
160 | angiotensin maturation (GO:0002003) | 2.81264834 |
161 | acidic amino acid transport (GO:0015800) | 2.80759506 |
162 | positive regulation of osteoclast differentiation (GO:0045672) | 2.79697890 |
163 | regulation of cholesterol esterification (GO:0010872) | 2.78279474 |
164 | phospholipid homeostasis (GO:0055091) | 2.77876373 |
165 | glial cell migration (GO:0008347) | 2.77043625 |
166 | * myeloid leukocyte migration (GO:0097529) | 2.76496392 |
167 | iron ion import (GO:0097286) | 2.75519789 |
168 | myeloid leukocyte activation (GO:0002274) | 2.75125374 |
169 | lipopolysaccharide metabolic process (GO:0008653) | 2.75108698 |
170 | intracellular pH reduction (GO:0051452) | 2.75022212 |
171 | regulation of vitamin metabolic process (GO:0030656) | 2.74865539 |
172 | ganglioside metabolic process (GO:0001573) | 2.73739972 |
173 | complement activation (GO:0006956) | 2.72061433 |
174 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.71312714 |
175 | response to cholesterol (GO:0070723) | 2.69768294 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.77959077 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.50758836 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.70162379 |
4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.69224741 |
5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.58813600 |
6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.61979873 |
7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.49075304 |
8 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.48134013 |
9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.99032461 |
10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.69627296 |
11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.53492533 |
12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.50796966 |
13 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 2.45705430 |
14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.45062036 |
15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.40900345 |
16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.34711009 |
17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.23779360 |
18 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.23659748 |
19 | EGR1_19032775_ChIP-ChIP_M12_Human | 2.13020593 |
20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.00181067 |
21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.94180729 |
22 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93634869 |
23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.89923768 |
24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.84442115 |
25 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.81981291 |
26 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.73579760 |
27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.72030947 |
28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69516430 |
29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.69203173 |
30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.67292450 |
31 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.66338696 |
32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62449712 |
33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.57794824 |
34 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.51378139 |
35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49267887 |
36 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49215915 |
37 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.48817485 |
38 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.48257576 |
39 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.48128780 |
40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.47537241 |
41 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.46715102 |
42 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.45710884 |
43 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.43054238 |
44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41872552 |
45 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.40966278 |
46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.39421474 |
47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39343134 |
48 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35945338 |
49 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.35458074 |
50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34048187 |
51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.32741567 |
52 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.32292294 |
53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.31628575 |
54 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.31054650 |
55 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.27856484 |
56 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27330609 |
57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21817647 |
58 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.21667377 |
59 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.20997352 |
60 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20897419 |
61 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.20122902 |
62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19695787 |
63 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19654176 |
64 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.17666226 |
65 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.16166053 |
66 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.15760948 |
67 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.15760948 |
68 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.15760948 |
69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15726736 |
70 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.14984084 |
71 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13533088 |
72 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.13130289 |
73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11778144 |
74 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11689461 |
75 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10553876 |
76 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.10390367 |
77 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08553580 |
78 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06476046 |
79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05704487 |
80 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05296610 |
81 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02595233 |
82 | MAF_26560356_Chip-Seq_TH1_Human | 1.02249309 |
83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01992219 |
84 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01894778 |
85 | CJUN_26792858_Chip-Seq_BT549_Human | 1.01257224 |
86 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.01072794 |
87 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98614494 |
88 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98143057 |
89 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98115851 |
90 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97912642 |
91 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.96888148 |
92 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95771617 |
93 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94273665 |
94 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.93973900 |
95 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.93006653 |
96 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91815109 |
97 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91644875 |
98 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90909110 |
99 | GATA1_22025678_ChIP-Seq_K562_Human | 0.90658053 |
100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.90007214 |
101 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.88915324 |
102 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88235619 |
103 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.87798581 |
104 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.87676718 |
105 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87074550 |
106 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87074550 |
107 | MYB_26560356_Chip-Seq_TH2_Human | 0.86995560 |
108 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.86411348 |
109 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.85375981 |
110 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.84586927 |
111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.82688208 |
112 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81199633 |
113 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.80339624 |
114 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.80238546 |
115 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.79770155 |
116 | MYB_26560356_Chip-Seq_TH1_Human | 0.78982072 |
117 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78919110 |
118 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78437705 |
119 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.78424253 |
120 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.77526172 |
121 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.77348079 |
122 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.77043297 |
123 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77043297 |
124 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.75233332 |
125 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.73560207 |
126 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.73083821 |
127 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.72523254 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009840_abnormal_foam_cell | 4.92957553 |
2 | MP0002254_reproductive_system_inflammat | 4.25718106 |
3 | MP0002148_abnormal_hypersensitivity_rea | 4.05713706 |
4 | MP0003436_decreased_susceptibility_to | 4.03273780 |
5 | MP0005058_abnormal_lysosome_morphology | 4.01467894 |
6 | MP0001835_abnormal_antigen_presentation | 3.83415690 |
7 | MP0002419_abnormal_innate_immunity | 3.15981440 |
8 | MP0003195_calcinosis | 3.09267096 |
9 | MP0005451_abnormal_body_composition | 3.04671804 |
10 | MP0003191_abnormal_cellular_cholesterol | 2.98455132 |
11 | MP0005000_abnormal_immune_tolerance | 2.75610808 |
12 | MP0003690_abnormal_glial_cell | 2.67808105 |
13 | MP0002877_abnormal_melanocyte_morpholog | 2.58460067 |
14 | MP0000343_altered_response_to | 2.56799802 |
15 | MP0003724_increased_susceptibility_to | 2.56491405 |
16 | MP0009278_abnormal_bone_marrow | 2.49682757 |
17 | MP0005025_abnormal_response_to | 2.48323451 |
18 | MP0002452_abnormal_antigen_presenting | 2.38436276 |
19 | MP0001800_abnormal_humoral_immune | 2.37640711 |
20 | MP0005671_abnormal_response_to | 2.30021685 |
21 | MP0003303_peritoneal_inflammation | 2.29058840 |
22 | MP0001533_abnormal_skeleton_physiology | 2.27639131 |
23 | MP0005464_abnormal_platelet_physiology | 2.25306928 |
24 | MP0006082_CNS_inflammation | 2.25028424 |
25 | MP0009785_altered_susceptibility_to | 2.21766178 |
26 | MP0002139_abnormal_hepatobiliary_system | 2.20157215 |
27 | MP0003806_abnormal_nucleotide_metabolis | 2.19293370 |
28 | MP0002723_abnormal_immune_serum | 2.15176312 |
29 | MP0002405_respiratory_system_inflammati | 2.02922523 |
30 | * MP0005387_immune_system_phenotype | 2.01029155 |
31 | * MP0001790_abnormal_immune_system | 2.01029155 |
32 | MP0003075_altered_response_to | 2.00302555 |
33 | MP0000604_amyloidosis | 1.98185102 |
34 | MP0002420_abnormal_adaptive_immunity | 1.94161094 |
35 | MP0005365_abnormal_bile_salt | 1.93753063 |
36 | MP0003329_amyloid_beta_deposits | 1.91986410 |
37 | MP0000685_abnormal_immune_system | 1.91086299 |
38 | MP0001819_abnormal_immune_cell | 1.90861109 |
39 | MP0001853_heart_inflammation | 1.84684934 |
40 | MP0005397_hematopoietic_system_phenotyp | 1.81867295 |
41 | MP0001545_abnormal_hematopoietic_system | 1.81867295 |
42 | MP0003279_aneurysm | 1.80712756 |
43 | MP0001845_abnormal_inflammatory_respons | 1.69315267 |
44 | MP0004233_abnormal_muscle_weight | 1.66281080 |
45 | MP0002138_abnormal_hepatobiliary_system | 1.62799228 |
46 | MP0005085_abnormal_gallbladder_physiolo | 1.62754361 |
47 | MP0008469_abnormal_protein_level | 1.55922144 |
48 | MP0004510_myositis | 1.46607929 |
49 | MP0009764_decreased_sensitivity_to | 1.45579850 |
50 | MP0003656_abnormal_erythrocyte_physiolo | 1.44760624 |
51 | MP0010368_abnormal_lymphatic_system | 1.43674869 |
52 | MP0005164_abnormal_response_to | 1.42919658 |
53 | MP0003828_pulmonary_edema | 1.40999300 |
54 | MP0002277_abnormal_respiratory_mucosa | 1.38820849 |
55 | MP0010234_abnormal_vibrissa_follicle | 1.38685766 |
56 | MP0005310_abnormal_salivary_gland | 1.35364167 |
57 | MP0004883_abnormal_blood_vessel | 1.33543905 |
58 | MP0004019_abnormal_vitamin_homeostasis | 1.33212314 |
59 | MP0001727_abnormal_embryo_implantation | 1.30990767 |
60 | MP0002998_abnormal_bone_remodeling | 1.30459286 |
61 | MP0002638_abnormal_pupillary_reflex | 1.28621012 |
62 | MP0009333_abnormal_splenocyte_physiolog | 1.27038232 |
63 | MP0000716_abnormal_immune_system | 1.20877386 |
64 | MP0000689_abnormal_spleen_morphology | 1.17397803 |
65 | MP0005390_skeleton_phenotype | 1.15055197 |
66 | MP0008260_abnormal_autophagy | 1.14674049 |
67 | MP0005167_abnormal_blood-brain_barrier | 1.12601293 |
68 | MP0005166_decreased_susceptibility_to | 1.11534892 |
69 | MP0003453_abnormal_keratinocyte_physiol | 1.10504318 |
70 | MP0002132_abnormal_respiratory_system | 1.08909336 |
71 | MP0010155_abnormal_intestine_physiology | 1.08513649 |
72 | MP0003091_abnormal_cell_migration | 1.07993195 |
73 | MP0001851_eye_inflammation | 1.07701348 |
74 | MP0000015_abnormal_ear_pigmentation | 1.06315185 |
75 | MP0009763_increased_sensitivity_to | 1.05993398 |
76 | MP0000249_abnormal_blood_vessel | 1.01698594 |
77 | MP0002398_abnormal_bone_marrow | 1.00304506 |
78 | MP0002295_abnormal_pulmonary_circulatio | 0.99741479 |
79 | MP0002429_abnormal_blood_cell | 0.99551870 |
80 | MP0004947_skin_inflammation | 0.97955172 |
81 | MP0003183_abnormal_peptide_metabolism | 0.95322888 |
82 | MP0000767_abnormal_smooth_muscle | 0.93921288 |
83 | MP0003448_altered_tumor_morphology | 0.93737686 |
84 | MP0002896_abnormal_bone_mineralization | 0.92935243 |
85 | MP0000920_abnormal_myelination | 0.92805501 |
86 | MP0004782_abnormal_surfactant_physiolog | 0.91435738 |
87 | MP0005174_abnormal_tail_pigmentation | 0.89223093 |
88 | MP0002722_abnormal_immune_system | 0.89192774 |
89 | MP0003172_abnormal_lysosome_physiology | 0.88578093 |
90 | MP0004147_increased_porphyrin_level | 0.88439459 |
91 | MP0008875_abnormal_xenobiotic_pharmacok | 0.88351858 |
92 | MP0010329_abnormal_lipoprotein_level | 0.87869257 |
93 | MP0000609_abnormal_liver_physiology | 0.86554491 |
94 | MP0001186_pigmentation_phenotype | 0.85963022 |
95 | MP0005023_abnormal_wound_healing | 0.85284304 |
96 | MP0008438_abnormal_cutaneous_collagen | 0.84043122 |
97 | MP0000569_abnormal_digit_pigmentation | 0.83733805 |
98 | MP0002075_abnormal_coat/hair_pigmentati | 0.83607832 |
99 | MP0008874_decreased_physiological_sensi | 0.83544329 |
100 | MP0001666_abnormal_nutrient_absorption | 0.83500709 |
101 | MP0003186_abnormal_redox_activity | 0.80606214 |
102 | MP0009115_abnormal_fat_cell | 0.80007594 |
103 | MP0002136_abnormal_kidney_physiology | 0.77838031 |
104 | MP0003300_gastrointestinal_ulcer | 0.76449655 |
105 | MP0005647_abnormal_sex_gland | 0.73781481 |
106 | MP0005076_abnormal_cell_differentiation | 0.73570988 |
107 | MP0001915_intracranial_hemorrhage | 0.73194045 |
108 | MP0005165_increased_susceptibility_to | 0.72139943 |
109 | MP0002166_altered_tumor_susceptibility | 0.72133490 |
110 | MP0002837_dystrophic_cardiac_calcinosis | 0.71469580 |
111 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70374709 |
112 | MP0003795_abnormal_bone_structure | 0.70260802 |
113 | MP0003632_abnormal_nervous_system | 0.70056754 |
114 | MP0000465_gastrointestinal_hemorrhage | 0.69058779 |
115 | MP0004808_abnormal_hematopoietic_stem | 0.68965563 |
116 | MP0002090_abnormal_vision | 0.68707850 |
117 | MP0009765_abnormal_xenobiotic_induced | 0.66639602 |
118 | MP0005646_abnormal_pituitary_gland | 0.66580820 |
119 | MP0000858_altered_metastatic_potential | 0.66086031 |
120 | MP0003763_abnormal_thymus_physiology | 0.63056503 |
121 | MP0005360_urolithiasis | 0.62840600 |
122 | MP0005171_absent_coat_pigmentation | 0.62107470 |
123 | MP0003633_abnormal_nervous_system | 0.57895989 |
124 | MP0002396_abnormal_hematopoietic_system | 0.56419525 |
125 | MP0001873_stomach_inflammation | 0.55524772 |
126 | MP0000371_diluted_coat_color | 0.55072925 |
127 | MP0005197_abnormal_uvea_morphology | 0.53627880 |
128 | MP0005248_abnormal_Harderian_gland | 0.52968575 |
129 | MP0002118_abnormal_lipid_homeostasis | 0.51809634 |
130 | MP0005332_abnormal_amino_acid | 0.50954248 |
131 | MP0005319_abnormal_enzyme/_coenzyme | 0.50914282 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Systemic lupus erythematosus (HP:0002725) | 9.59231757 |
2 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.12337287 |
3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.12337287 |
4 | Abnormality of glycolipid metabolism (HP:0010969) | 7.12337287 |
5 | Glomerulonephritis (HP:0000099) | 6.54141666 |
6 | Recurrent abscess formation (HP:0002722) | 6.20700436 |
7 | Complement deficiency (HP:0004431) | 5.75972513 |
8 | Recurrent bacterial skin infections (HP:0005406) | 5.67215623 |
9 | Abnormality of complement system (HP:0005339) | 5.34660571 |
10 | Eczematoid dermatitis (HP:0000976) | 5.25221930 |
11 | Epidermoid cyst (HP:0200040) | 5.23845955 |
12 | Disinhibition (HP:0000734) | 5.16762865 |
13 | Vacuolated lymphocytes (HP:0001922) | 4.98101166 |
14 | Axonal loss (HP:0003447) | 4.58885305 |
15 | Spontaneous hematomas (HP:0007420) | 4.58475819 |
16 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 4.51781440 |
17 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.43763277 |
18 | Abnormality of the periventricular white matter (HP:0002518) | 4.16348048 |
19 | Joint hemorrhage (HP:0005261) | 4.02519607 |
20 | Skin nodule (HP:0200036) | 4.02184347 |
21 | Prostate neoplasm (HP:0100787) | 3.97218735 |
22 | Agnosia (HP:0010524) | 3.84870650 |
23 | Abnormality of macrophages (HP:0004311) | 3.77816775 |
24 | Dysostosis multiplex (HP:0000943) | 3.74047836 |
25 | Nephritis (HP:0000123) | 3.70190715 |
26 | Neurofibrillary tangles (HP:0002185) | 3.67125180 |
27 | Loss of speech (HP:0002371) | 3.52505061 |
28 | Upper motor neuron abnormality (HP:0002127) | 3.51027330 |
29 | Metaphyseal irregularity (HP:0003025) | 3.49105826 |
30 | Mediastinal lymphadenopathy (HP:0100721) | 3.40262965 |
31 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.33130881 |
32 | Increased cerebral lipofuscin (HP:0011813) | 3.28905391 |
33 | Progressive visual loss (HP:0000529) | 3.24083743 |
34 | Myocardial infarction (HP:0001658) | 3.18629603 |
35 | Inappropriate behavior (HP:0000719) | 3.00753879 |
36 | Abnormality of the common coagulation pathway (HP:0010990) | 3.00613238 |
37 | Multiple lipomas (HP:0001012) | 2.99589275 |
38 | Orchitis (HP:0100796) | 2.97016743 |
39 | Retinal atrophy (HP:0001105) | 2.96877312 |
40 | Recurrent skin infections (HP:0001581) | 2.96677178 |
41 | Peripheral demyelination (HP:0011096) | 2.96630710 |
42 | Pustule (HP:0200039) | 2.92625203 |
43 | Myositis (HP:0100614) | 2.86601840 |
44 | Nausea (HP:0002018) | 2.85463901 |
45 | Basal ganglia calcification (HP:0002135) | 2.80577182 |
46 | Osteolytic defects of the hand bones (HP:0009699) | 2.66776926 |
47 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.66776926 |
48 | Gingivitis (HP:0000230) | 2.65698889 |
49 | Mucopolysacchariduria (HP:0008155) | 2.65008696 |
50 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.65008696 |
51 | Pseudobulbar signs (HP:0002200) | 2.61199189 |
52 | Retrobulbar optic neuritis (HP:0100654) | 2.58396538 |
53 | Optic neuritis (HP:0100653) | 2.58396538 |
54 | Cerebral inclusion bodies (HP:0100314) | 2.57966135 |
55 | Malnutrition (HP:0004395) | 2.55890600 |
56 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.54009243 |
57 | Protuberant abdomen (HP:0001538) | 2.46342101 |
58 | Hepatosplenomegaly (HP:0001433) | 2.44980093 |
59 | Hypoalphalipoproteinemia (HP:0003233) | 2.42959831 |
60 | Dysphonia (HP:0001618) | 2.40823013 |
61 | Abnormality of the prostate (HP:0008775) | 2.36684420 |
62 | Obstructive lung disease (HP:0006536) | 2.36666154 |
63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.36666154 |
64 | Thin bony cortex (HP:0002753) | 2.34656358 |
65 | Panhypogammaglobulinemia (HP:0003139) | 2.31400777 |
66 | Diminished motivation (HP:0000745) | 2.31322428 |
67 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.31266150 |
68 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.29457375 |
69 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.29457375 |
70 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.29457375 |
71 | Recurrent fungal infections (HP:0002841) | 2.28379170 |
72 | Periodontitis (HP:0000704) | 2.28231974 |
73 | Colitis (HP:0002583) | 2.28209586 |
74 | Pathologic fracture (HP:0002756) | 2.26837425 |
75 | Facial diplegia (HP:0001349) | 2.25213032 |
76 | Prolonged bleeding time (HP:0003010) | 2.22084477 |
77 | Stomatitis (HP:0010280) | 2.20182720 |
78 | Pulmonary infiltrates (HP:0002113) | 2.19111871 |
79 | Prolonged partial thromboplastin time (HP:0003645) | 2.17346778 |
80 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.16813387 |
81 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.14220665 |
82 | Urticaria (HP:0001025) | 2.14151257 |
83 | Abnormality of B cell number (HP:0010975) | 2.13687238 |
84 | B lymphocytopenia (HP:0010976) | 2.13687238 |
85 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.10092724 |
86 | Apathy (HP:0000741) | 2.08719967 |
87 | Recurrent viral infections (HP:0004429) | 2.06384199 |
88 | Delusions (HP:0000746) | 2.06150051 |
89 | Epistaxis (HP:0000421) | 2.05701467 |
90 | Dementia (HP:0000726) | 2.05196535 |
91 | Steatorrhea (HP:0002570) | 2.04531116 |
92 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.03636199 |
93 | Multiple enchondromatosis (HP:0005701) | 2.01825979 |
94 | Mutism (HP:0002300) | 2.00907307 |
95 | Cellulitis (HP:0100658) | 2.00037290 |
96 | Keratoconjunctivitis sicca (HP:0001097) | 1.98648284 |
97 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.98418249 |
98 | Tetraparesis (HP:0002273) | 1.97422664 |
99 | Mesangial abnormality (HP:0001966) | 1.97288084 |
100 | Petechiae (HP:0000967) | 1.96835337 |
101 | Thick nail (HP:0001805) | 1.96674395 |
102 | Neuronal loss in central nervous system (HP:0002529) | 1.96096184 |
103 | Increased serum ferritin (HP:0003281) | 1.95743502 |
104 | T lymphocytopenia (HP:0005403) | 1.95526284 |
105 | Bone pain (HP:0002653) | 1.94749544 |
106 | Xanthomatosis (HP:0000991) | 1.93345832 |
107 | Stomach cancer (HP:0012126) | 1.93085252 |
108 | J-shaped sella turcica (HP:0002680) | 1.92477583 |
109 | Autoimmune thrombocytopenia (HP:0001973) | 1.91447307 |
110 | Deep venous thrombosis (HP:0002625) | 1.91128171 |
111 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.90818561 |
112 | Recurrent cutaneous fungal infections (HP:0011370) | 1.90818561 |
113 | Arthropathy (HP:0003040) | 1.90291072 |
114 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.89708214 |
115 | Hematochezia (HP:0002573) | 1.88762332 |
116 | Asymmetric septal hypertrophy (HP:0001670) | 1.88575053 |
117 | Esophageal varix (HP:0002040) | 1.87857858 |
118 | Osteomyelitis (HP:0002754) | 1.87437359 |
119 | Recurrent pneumonia (HP:0006532) | 1.87369566 |
120 | Abnormality of iron homeostasis (HP:0011031) | 1.87345947 |
121 | Interstitial pulmonary disease (HP:0006530) | 1.87240333 |
122 | Premature loss of primary teeth (HP:0006323) | 1.86452254 |
123 | Amyloidosis (HP:0011034) | 1.85552224 |
124 | Intrahepatic cholestasis (HP:0001406) | 1.84803181 |
125 | Thoracic kyphosis (HP:0002942) | 1.83002124 |
126 | Gastrointestinal infarctions (HP:0005244) | 1.82057476 |
127 | Generalized aminoaciduria (HP:0002909) | 1.81503414 |
128 | Purpura (HP:0000979) | 1.80675610 |
129 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.80563478 |
130 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.80382085 |
131 | Meningitis (HP:0001287) | 1.78605007 |
132 | Abnormality of the pleura (HP:0002103) | 1.78588290 |
133 | Inflammation of the large intestine (HP:0002037) | 1.77652250 |
134 | Keratoconjunctivitis (HP:0001096) | 1.77390059 |
135 | Albinism (HP:0001022) | 1.77334961 |
136 | Poor head control (HP:0002421) | 1.76743551 |
137 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.76340552 |
138 | Cholelithiasis (HP:0001081) | 1.75659538 |
139 | Failure to thrive in infancy (HP:0001531) | 1.74268040 |
140 | Personality changes (HP:0000751) | 1.73320461 |
141 | Abnormality of T cell number (HP:0011839) | 1.71494899 |
142 | Progressive neurologic deterioration (HP:0002344) | 1.71400237 |
143 | Enlarged epiphyses (HP:0010580) | 1.71045798 |
144 | Fat malabsorption (HP:0002630) | 1.70770762 |
145 | Nuclear cataract (HP:0100018) | 1.69916502 |
146 | Symptomatic seizures (HP:0011145) | 1.69767980 |
147 | Prolonged neonatal jaundice (HP:0006579) | 1.69297199 |
148 | Amaurosis fugax (HP:0100576) | 1.69286295 |
149 | Increased CSF protein (HP:0002922) | 1.65136183 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K10 | 7.77470452 |
2 | PDK2 | 5.72647917 |
3 | MAP3K14 | 4.70351365 |
4 | BLK | 4.36843920 |
5 | TYK2 | 3.81809909 |
6 | NME2 | 3.41233670 |
7 | ACVR1B | 3.14993007 |
8 | TGFBR2 | 3.06632796 |
9 | IRAK3 | 2.90096072 |
10 | GRK7 | 2.76821676 |
11 | NEK9 | 2.34398486 |
12 | IRAK4 | 2.28266928 |
13 | CAMKK2 | 2.16681450 |
14 | IKBKB | 1.99295229 |
15 | TBK1 | 1.89171155 |
16 | EIF2AK2 | 1.81440249 |
17 | EPHB1 | 1.72588352 |
18 | CLK1 | 1.70708158 |
19 | IKBKE | 1.66525437 |
20 | ERN1 | 1.63408471 |
21 | TEC | 1.63237291 |
22 | BTK | 1.49218882 |
23 | BMPR2 | 1.46071081 |
24 | FES | 1.46012937 |
25 | MAP3K13 | 1.40391840 |
26 | NEK6 | 1.40172037 |
27 | PDPK1 | 1.39094279 |
28 | JAK1 | 1.32423535 |
29 | DDR2 | 1.31196646 |
30 | RIPK4 | 1.30116728 |
31 | CSF1R | 1.28287626 |
32 | MAP4K1 | 1.27746780 |
33 | DMPK | 1.25450821 |
34 | PIM2 | 1.23883779 |
35 | STK10 | 1.17398510 |
36 | LIMK1 | 1.16970827 |
37 | LYN | 1.15803243 |
38 | MAP3K2 | 1.15447898 |
39 | PDK1 | 1.15345296 |
40 | HCK | 1.15152508 |
41 | MAP2K3 | 1.14672570 |
42 | TXK | 1.11469754 |
43 | MAP3K11 | 1.11256492 |
44 | CHUK | 1.09547305 |
45 | TESK2 | 1.05926805 |
46 | LCK | 1.05184278 |
47 | SYK | 1.03417252 |
48 | CSK | 1.02064891 |
49 | ERBB4 | 0.98655798 |
50 | KSR2 | 0.96613601 |
51 | TRPM7 | 0.96145506 |
52 | TAOK3 | 0.90356217 |
53 | PBK | 0.89901469 |
54 | JAK2 | 0.89718532 |
55 | MOS | 0.88192721 |
56 | MAP3K8 | 0.86832162 |
57 | YES1 | 0.86029111 |
58 | TAOK2 | 0.85129074 |
59 | ERBB3 | 0.83714843 |
60 | MAP3K3 | 0.82425656 |
61 | CDC42BPA | 0.81148495 |
62 | MST4 | 0.80158351 |
63 | PIM1 | 0.77942222 |
64 | ZAP70 | 0.76962899 |
65 | BMX | 0.76649757 |
66 | PIK3CG | 0.75638830 |
67 | SGK3 | 0.75616390 |
68 | KIT | 0.74667351 |
69 | JAK3 | 0.74586320 |
70 | IGF1R | 0.71318779 |
71 | PKN1 | 0.71175419 |
72 | PRKG2 | 0.70484009 |
73 | ADRBK2 | 0.66773979 |
74 | PRKCD | 0.64728314 |
75 | IRAK2 | 0.64456694 |
76 | EGFR | 0.63848818 |
77 | ABL2 | 0.62251442 |
78 | MAPK12 | 0.61079166 |
79 | PRPF4B | 0.60980979 |
80 | FGR | 0.59758075 |
81 | MST1R | 0.58981129 |
82 | ARAF | 0.58480096 |
83 | EPHA3 | 0.58232272 |
84 | ABL1 | 0.55706545 |
85 | GRK5 | 0.55137576 |
86 | MAPK4 | 0.53637230 |
87 | EIF2AK3 | 0.53054574 |
88 | MARK3 | 0.52795682 |
89 | CAMKK1 | 0.51441991 |
90 | RIPK1 | 0.50397962 |
91 | MAP3K5 | 0.48987633 |
92 | MAPKAPK2 | 0.48765861 |
93 | CAMK4 | 0.46990886 |
94 | ITK | 0.46949600 |
95 | SIK2 | 0.46817189 |
96 | RPS6KA1 | 0.46044367 |
97 | MET | 0.45093670 |
98 | CAMK1D | 0.44229160 |
99 | MAPK7 | 0.43680673 |
100 | PAK4 | 0.43126294 |
101 | MAP3K1 | 0.41118270 |
102 | GSK3A | 0.41112888 |
103 | RPS6KL1 | 0.39975982 |
104 | RPS6KC1 | 0.39975982 |
105 | FGFR3 | 0.39557300 |
106 | EEF2K | 0.39328696 |
107 | CDK6 | 0.39025652 |
108 | INSR | 0.38554795 |
109 | MAP2K2 | 0.37123959 |
110 | FYN | 0.36329501 |
111 | ALK | 0.34789655 |
112 | ERBB2 | 0.34482578 |
113 | RPS6KA6 | 0.34038346 |
114 | PRKACB | 0.33873557 |
115 | SCYL2 | 0.33865960 |
116 | KSR1 | 0.32884827 |
117 | PRKACG | 0.32705619 |
118 | CAMK2G | 0.32361679 |
119 | CAMK1G | 0.31646065 |
120 | IRAK1 | 0.31263372 |
121 | PRKG1 | 0.30498490 |
122 | STK24 | 0.30331064 |
123 | CAMK2D | 0.29269086 |
124 | RPS6KA2 | 0.28352650 |
125 | MAPK9 | 0.28006482 |
126 | MAP3K6 | 0.27082823 |
127 | EIF2AK1 | 0.24697670 |
128 | PTK2B | 0.24544192 |
129 | MATK | 0.24516316 |
130 | PRKD1 | 0.23709155 |
131 | PTK6 | 0.23307239 |
132 | HIPK2 | 0.23146492 |
133 | INSRR | 0.23125939 |
134 | MAPK3 | 0.23109572 |
135 | TTN | 0.20969191 |
136 | MAPK15 | 0.20682839 |
137 | SGK2 | 0.20314919 |
138 | PTK2 | 0.19402428 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 6.55762014 |
2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.46101797 |
3 | Pertussis_Homo sapiens_hsa05133 | 2.83191899 |
4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.66071456 |
5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.54463415 |
6 | Lysosome_Homo sapiens_hsa04142 | 2.48821031 |
7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.30741508 |
8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.27198215 |
9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.13715987 |
10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.06959566 |
11 | Allograft rejection_Homo sapiens_hsa05330 | 2.03784697 |
12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.02515486 |
13 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.91894635 |
14 | Legionellosis_Homo sapiens_hsa05134 | 1.91890370 |
15 | Tuberculosis_Homo sapiens_hsa05152 | 1.88627078 |
16 | Phagosome_Homo sapiens_hsa04145 | 1.81341638 |
17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.75823057 |
18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.74278982 |
19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74114305 |
20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.70263353 |
21 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.70049357 |
22 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.68307660 |
23 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.60791175 |
24 | Malaria_Homo sapiens_hsa05144 | 1.58093192 |
25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.56495773 |
26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.53584435 |
27 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.50562422 |
28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.49990105 |
29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.49036789 |
30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.47307042 |
31 | Galactose metabolism_Homo sapiens_hsa00052 | 1.44808177 |
32 | Asthma_Homo sapiens_hsa05310 | 1.40095023 |
33 | Salmonella infection_Homo sapiens_hsa05132 | 1.39599080 |
34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.34962422 |
35 | Measles_Homo sapiens_hsa05162 | 1.34462846 |
36 | Prion diseases_Homo sapiens_hsa05020 | 1.34390321 |
37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.28529427 |
38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.28510080 |
39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.25642074 |
40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.18417880 |
41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.16925150 |
42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09581342 |
43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.08510519 |
44 | ABC transporters_Homo sapiens_hsa02010 | 1.04693238 |
45 | Shigellosis_Homo sapiens_hsa05131 | 1.04485942 |
46 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.02356084 |
47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.02076245 |
48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.98871089 |
49 | Apoptosis_Homo sapiens_hsa04210 | 0.97426170 |
50 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.94894297 |
51 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92094848 |
52 | Influenza A_Homo sapiens_hsa05164 | 0.90238105 |
53 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.90186519 |
54 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83181194 |
55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82478034 |
56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.82261190 |
57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78837627 |
58 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77641227 |
59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77278009 |
60 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75504140 |
61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73219476 |
62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.72561022 |
63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72522379 |
64 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.71283316 |
65 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.70036442 |
66 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.67045068 |
67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66979784 |
68 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65899251 |
69 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.65899029 |
70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63317633 |
71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61988636 |
72 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.61820987 |
73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60110163 |
74 | Hepatitis C_Homo sapiens_hsa05160 | 0.59561882 |
75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59003231 |
76 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.58528586 |
77 | Amoebiasis_Homo sapiens_hsa05146 | 0.58477484 |
78 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57949633 |
79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57408807 |
80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56739920 |
81 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56357336 |
82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55334939 |
83 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55245999 |
84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52679273 |
85 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.50603963 |
86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49661649 |
87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49338900 |
88 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48977589 |
89 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.48415239 |
90 | Mineral absorption_Homo sapiens_hsa04978 | 0.48176022 |
91 | Hepatitis B_Homo sapiens_hsa05161 | 0.47680443 |
92 | Platelet activation_Homo sapiens_hsa04611 | 0.47580330 |
93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47286392 |
94 | Carbon metabolism_Homo sapiens_hsa01200 | 0.46150908 |
95 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.45272142 |
96 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.45141475 |
97 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.43746247 |
98 | Bladder cancer_Homo sapiens_hsa05219 | 0.42057103 |
99 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.40517081 |
100 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.39621465 |
101 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.37270285 |
102 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.37114940 |
103 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36608412 |
104 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35617542 |
105 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.34283563 |
106 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.34048141 |
107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33440755 |
108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32209998 |
109 | Retinol metabolism_Homo sapiens_hsa00830 | 0.31214408 |
110 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.30453387 |
111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30009664 |
112 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.28864421 |
113 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.27563019 |
114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.27514810 |
115 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.26860474 |
116 | Peroxisome_Homo sapiens_hsa04146 | 0.26593869 |
117 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.25424608 |
118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23158091 |
119 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.21693017 |
120 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.21067976 |
121 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.20146856 |
122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.20062956 |
123 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.19930002 |
124 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.19310558 |
125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.18849738 |
126 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.17813550 |
127 | Endocytosis_Homo sapiens_hsa04144 | 0.17251048 |
128 | Insulin resistance_Homo sapiens_hsa04931 | 0.16012647 |